Today's Pre-Open Stock Movers

Arcus Biosciences (NYSE: RCUS) 47.5% HIGHER; Gilead (NASDAQ: GILD) is considering acquiring a stake in Arcus Biosciences (NYSE: RCUS), according to Bloomberg, citing people familiar with the matter.

Diamond Offshore Drilling (NYSE: DO) 37.5% LOWER; elected not to make the semiannual interest payment due in respect of its 5.70% Senior Notes

The Lovesac Company (NASDAQ: LOVE) 24.2% HIGHER; reported Q4 EPS of $0.37, $0.04 better than the analyst estimate of $0.33. Revenue for the quarter came in at $92.2 million versus the consensus estimate of $90.64 million.

Antero Midstream (NYSE: AM) 16.8% HIGHER; said first quarter 2020 dividend is unchanged as compared to the fourth quarter of 2019.

Rite Aid (NYSE: RAD) 15% LOWER; reported Q4 EPS of ($0.37), $0.22 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.73 billion versus the consensus estimate of $5.59 billion.

Bed Bath & Beyond (NASDAQ: BBBY) 14.4% HIGHER; reported Q4 EPS of $0.38, $0.17 better than the analyst estimate of $0.21. Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.08 million. Comparable Sales Decrease 5.6%. The Company's first quarter and full-year 2020 results will be unfavorably impacted by the COVID-19 pandemic. The duration and extent of the pandemic is highly uncertain, and Bed Bath & Beyond's results could be impacted in ways that are difficult to predict today. Due to the level of market uncertainty, the Company will not provide further financial guidance for fiscal 2020 at this time.

Athersys, Inc. (NASDAQ: ATHX) 13.6% LOWER; intends to offer for sale $50 million of shares of its common stock, par value $0.001 per share (Common Stock), in an underwritten public offering. In addition, Athersys expects to grant the underwriters a 30-day option to purchase additional shares of Common Stock in an amount of up to 15% of the number of shares of Common Stock offered in the public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Compugen Ltd. (NASDAQ: CGEN) 11.4% HIGHER; gains on Arcus news

Calithera Biosciences, Inc. (Nasdaq: CALA) 10.8% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares of common stock are being offered by Calithera. Citigroup is acting as sole book-running manager for the offering. In connection with this offering, Calithera expects to grant Citigroup a 30-day option to purchase an additional 15% of the shares of common stock offered in the public offering.

Dynavax Technologies Corporation (Nasdaq: DVAX) 8.1% HIGHER; Dynavax Technologies and Sinovac Biotech Ltd. (NASDAQ: SVA) announced that they have entered into a collaboration to develop a vaccine to prevent COVID-19. The collaboration will evaluate the combination of Sinovac’s chemically inactivated coronavirus vaccine candidate, with Dynavax’s advanced adjuvant, CpG 1018 ^.

Lakeland Industries (NASDAQ: LAKE) 8.1% LOWER; reported Q4 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $26.36 million.

Co-Diagnostics, Inc. (Nasdaq: CODX) 8.1% HIGHER; announced today that OralDNA® Labs, a CLIA-certified laboratory, has recently validated a COVID-19 PCR test based on the Company's patented CoPrimer™ technology for use with saline oral rinse samples, and has notified the FDA of their intent to use the validated test in their CAP accredited high-complexity laboratory.

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) 7% HIGHER; Vanda and Northwell Health's research arm, The Feinstein Institutes for Medical Research, today announced enrollment of the first patient in Vanda's clinical trial, ODYSSEY VLY-686-3501 (NCT04326426), yesterday at Lenox Hill Hospital in New York City.

Goodyear Tire (NASDAQ: GT) 5.8% LOWER; offers prelim. Q1 results, temporarily suspends quarterly dividend, reduces 2020 capital expenditures

Square (NYSE: SQ) 4.9% LOWER; Raymond James downgraded from Market Perform to Underperform with a $41 fair value target, saying COVID-19 is the company's 'Kryptonite'.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) 2.9% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, the Company intends to grant the underwriters a thirty-day option to purchase up to an additional 15 percent of shares of its common stock offered in the public offering.

Plantronics (NYSE: PLT) 2.2% LOWER; Morgan Stanley downgraded from Equalweight to Underweight with a price target of $10.00 (from $8.00).